Overview

A Study to Test How Well Patients With Plaque Psoriasis Tolerate BI 730357 Over a Longer Period and How Effective it is

Status:
Completed

Trial end date:
2021-07-27

Target enrollment:

Participant gender:

Summary

To assess long-term safety, tolerability, and efficacy of BI 730357 in patients with moderate to severe chronic plaque psoriasis.

Phase:

Phase 2

Details

Lead Sponsor:

Boehringer Ingelheim